Patient Voices in Rheumatic Immune-related Adverse Events

Rheum Dis Clin North Am. 2024 May;50(2):241-254. doi: 10.1016/j.rdc.2024.01.006. Epub 2024 Feb 22.

Abstract

Patients with cancer considering immune checkpoint inhibitor (ICI) therapy often look for health information and peer support through online communities. The authors used social media content analysis to obtain the perspectives of patients receiving ICI treatment about immune-related adverse events (irAEs), with particular focus on rheumatological symptoms. The most reported rheumatic symptom was joint pain. Other commonly reported symptoms included muscle pain, joint stiffness, arthritis, myositis, bone pain, back pain, and tendon/ligament pain. A few users reported development of rheumatic diseases. The authors' analyses allowed for cataloging and assessment of patient and caregiver experiences with ICI therapy and rheumatic irAEs.

Keywords: Immune checkpoint inhibitors; Immune-related adverse events; Immunotherapy; Patient perspective; Qualitative research; Social media content analysis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Immune Checkpoint Inhibitors* / adverse effects
  • Neoplasms* / drug therapy
  • Neoplasms* / immunology
  • Rheumatic Diseases* / drug therapy
  • Rheumatic Diseases* / immunology
  • Social Media

Substances

  • Immune Checkpoint Inhibitors